rotenone and rifampin
rotenone has been researched along with rifampin in 13 studies
Research
Studies (13)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bi, W; Jing, X; Liang, Y; Liu, J; Shi, Q; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z | 1 |
| Bi, W; Chen, Y; Jing, X; Liang, Y; Lin, D; Liu, J; Liu, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z | 1 |
| Chen, Y; Jing, X; Lei, M; Liang, Y; Lin, D; Liu, J; Peng, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z; Zheng, D; Zhou, T | 1 |
| Chen, Y; Huang, K; Jing, X; Lei, M; Liang, Y; Lin, D; Liu, J; Peng, S; Tao, E; Wu, X; Xiao, S; Yang, L; Zeng, Z; Zheng, D; Zhou, T | 1 |
| Chen, Y; Huang, K; Jing, X; Lei, M; Liang, Y; Lin, D; Peng, S; Tao, E; Wu, X; Zeng, Z; Zheng, D; Zhou, T | 1 |
| Chen, Y; Huang, K; Jing, X; Liang, Y; Lin, D; Peng, S; Tao, E; Xie, Y; Zeng, Z; Zheng, D; Zhou, T | 1 |
| Ateş, PS; Emekli-Alturfan, E; Ünal, İ; Üstündağ, ÜV; Yurtsever, İ | 1 |
Other Studies
13 other study(ies) available for rotenone and rifampin
| Article | Year |
|---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Rifampicin protects PC12 cells from rotenone-induced cytotoxicity by activating GRP78 via PERK-eIF2α-ATF4 pathway.
Topics: Activating Transcription Factor 4; Activating Transcription Factor 6; Animals; Cell Death; DNA-Binding Proteins; eIF-2 Kinase; Electrophoresis, Gel, Two-Dimensional; Endoplasmic Reticulum Chaperone BiP; Endoribonucleases; Eukaryotic Initiation Factor-2; Heat-Shock Proteins; Neuroprotective Agents; PC12 Cells; Rats; Regulatory Factor X Transcription Factors; Rifampin; Rotenone; Signal Transduction; Time Factors; Transcription Factors | 2014 |
Rifampicin attenuates rotenone-induced inflammation via suppressing NLRP3 inflammasome activation in microglia.
Topics: Anti-Inflammatory Agents; Antiparkinson Agents; Carrier Proteins; Caspase 1; Cell Death; Cell Line; Cell Survival; Gene Expression; Humans; Interleukin-1beta; Membrane Potential, Mitochondrial; Microglia; Neuroimmunomodulation; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Reactive Oxygen Species; Rifampin; Rotenone | 2015 |
Rifampicin pre-treatment inhibits the toxicity of rotenone-induced PC12 cells by enhancing sumoylation modification of α-synuclein.
Topics: alpha-Synuclein; Animals; Antibiotics, Antitubercular; Antiparkinson Agents; Apoptosis; Cell Survival; Parkinson Disease, Secondary; PC12 Cells; Rats; Rifampin; Rotenone; Sumoylation | 2017 |
Rifampicin inhibits rotenone-induced microglial inflammation via enhancement of autophagy.
Topics: Analysis of Variance; Antirheumatic Agents; Autophagy; Cell Line, Tumor; Chloroquine; Coculture Techniques; Humans; Insecticides; Interleukin-1beta; Interleukin-6; Membrane Potential, Mitochondrial; Microglia; Microscopy, Electron, Transmission; Mitochondria; Neuroblastoma; Neuroprotective Agents; Reactive Oxygen Species; Rifampin; Rotenone | 2017 |
Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3β/CREB Signaling Pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cyclic AMP Response Element-Binding Protein; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rifampin; Rotenone; Signal Transduction | 2018 |
Rifampicin attenuates rotenone-treated microglia inflammation via improving lysosomal function.
Topics: Autophagosomes; Cell Survival; Cells, Cultured; Humans; Insecticides; Lysosomes; Microglia; Microtubule-Associated Proteins; Neuroprotective Agents; Rifampin; RNA, Small Interfering; Rotenone; Vacuolar Proton-Translocating ATPases | 2020 |
Rifampicin decreases neuroinflammation to maintain mitochondrial function and calcium homeostasis in rotenone-treated zebrafish.
Topics: Animals; Calcium; Homeostasis; Inflammation; Mitochondria; Neurodegenerative Diseases; Neuroinflammatory Diseases; Oxidative Stress; Rifampin; Rotenone; Zebrafish | 2022 |